跳至主要内容
临床试验/IRCT20151227025726N16
IRCT20151227025726N16已完成3 期

Evaluating the effect of ubiquinone (CoQ10) on the prevention of postoperative Acute Kidney Injury (AKI) following Coronary Artery Bypass Grafting surgery (CABG)

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • The patients who are candidates for Coronary Artery Bypass Graft surgery in Masih Daneshvari Hospital

排除标准

  • History of hypersensitivity reaction to ubiquinone
  • Chronic liver failure (Stage II & III)
  • Chronic kidney disease (Stage IV & V) or patients with Glomerular Filtration Rate of lower than 30 ml/min
  • Patient with INR of more than 2.5
  • Patients who receive anti-inflammatory agents at least two weeks before admission
  • Patients who undergo emergency CABG.

研究者

相似试验